ITC judge says Apple Watch’s redesigned blood oxygen feature doesn’t infringe Masimo patents

There are two new developments in Apple’s ongoing legal battle with health technology company Masimo over the Apple Watch’s blood oxygen feature.

First, an ITC Administrative Law Judge Monica Bhattacharyya found in an initial determination that Apple’s redesigned version of the Apple Watch’s blood oxygen feature does not infringe Masimo’s patents.

Second, the Federal Circuit has affirmed the ITC’s initial exclusion order, meaning the original version of the blood oxygen feature on Apple Watch is still banned in the United States.